These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 13860583)

  • 1. Immunity against tularemia: passive protection of mice by transfer of immune tissues.
    ALLEN WP
    J Exp Med; 1962 Feb; 115(2):411-20. PubMed ID: 13860583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine model for study of cell-mediated immunity: protection against death from fully virulent Francisella tularensis infection.
    Eigelsbach HT; Hunter DH; Janssen WA; Dangerfield HG; Rabinowitz SG
    Infect Immun; 1975 Nov; 12(5):999-1005. PubMed ID: 1193736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance.
    Anthony LS; Kongshavn PA
    Microb Pathog; 1987 Jan; 2(1):3-14. PubMed ID: 3507552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
    Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
    Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.
    Griffin AJ; Crane DD; Wehrly TD; Bosio CM
    Clin Vaccine Immunol; 2015 Jan; 22(1):119-28. PubMed ID: 25410207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological markers that correlate with protection immunity against tularemia infection.
    Firstova VV; Mokrievich AN; Pavlov VM; Gorbatov AA; Kombarova TI; Biketov SF; Dyatlov IA
    Adv Exp Med Biol; 2014; 808():15-23. PubMed ID: 24595607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung.
    Bar-On L; Cohen H; Elia U; Rotem S; Bercovich-Kinori A; Bar-Haim E; Chitlaru T; Cohen O
    Vaccine; 2017 Dec; 35(50):7001-7009. PubMed ID: 29102170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.
    Shen H; Chen W; Conlan JW
    Vaccine; 2004 Jun; 22(17-18):2116-21. PubMed ID: 15149767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
    Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis.
    Chen W; KuoLee R; Shen H; Conlan JW
    Microb Pathog; 2004 Jun; 36(6):311-8. PubMed ID: 15120157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive transfer of protective immunity against Brugia malayi in BALB/c mice.
    Hayashi Y; Nogami S; Nakamura M; Shirasaka A; Noda K
    Jpn J Exp Med; 1984 Aug; 54(4):183-7. PubMed ID: 6513102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ability of CpG oligonucleotides to protect mice against Francisella tularensis live vaccine strain but not fully virulent F. tularensis subspecies holarctica is reflected in cell-based assays.
    Rees DG; Hartley MG; Green M; Lukaszewski RA; Griffin KF; Atkins HS; Lyons R; Krieg AM; Titball RW
    Microb Pathog; 2013 Oct; 63():16-8. PubMed ID: 23707360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis.
    Shen H; Chen W; Conlan JW
    Microb Pathog; 2004 Aug; 37(2):107-10. PubMed ID: 15312850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated immunogenic parasites are essential in the transfer of immunity to virulent Plasmodium berghei.
    Celluzzi CM; Liem PL; van de Wiel T; Eling WM
    Immunology; 1995 Jul; 85(3):509-15. PubMed ID: 7558142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria.
    Ryden P; Twine S; Shen H; Harris G; Chen W; Sjostedt A; Conlan W
    Mol Immunol; 2013 May; 54(1):58-67. PubMed ID: 23201853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.
    Straskova A; Cerveny L; Spidlova P; Dankova V; Belcic D; Santic M; Stulik J
    Microbes Infect; 2012 Feb; 14(2):177-87. PubMed ID: 21930232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion and retention of pulmonary CD4
    Roberts LM; Wehrly TD; Crane DD; Bosio CM
    Vaccine; 2017 May; 35(19):2575-2581. PubMed ID: 28372827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Brucella cell-mediated immunity in mice vaccinated with a cell-wall fraction.
    Plommet M; Plommet AM
    Ann Rech Vet; 1987; 18(4):429-37. PubMed ID: 3451687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.